This document lists several proton pump inhibitors (PPIs) including their years of FDA approval. It notes that omeprazole was the first PPI approved in 1989, followed by lansoprazole in 1995 and pantoprazole in 2000. The document categorizes PPIs as first generation including omeprazole, lansoprazole, and pantoprazole which more promptly inhibit acid secretion and are more potent with longer duration. Rabeprazole and esomeprazole are categorized as second generation PPIs.
This document lists several proton pump inhibitors (PPIs) including their years of FDA approval. It notes that omeprazole was the first PPI approved in 1989, followed by lansoprazole in 1995 and pantoprazole in 2000. The document categorizes PPIs as first generation including omeprazole, lansoprazole, and pantoprazole which more promptly inhibit acid secretion and are more potent with longer duration. Rabeprazole and esomeprazole are categorized as second generation PPIs.
This document lists several proton pump inhibitors (PPIs) including their years of FDA approval. It notes that omeprazole was the first PPI approved in 1989, followed by lansoprazole in 1995 and pantoprazole in 2000. The document categorizes PPIs as first generation including omeprazole, lansoprazole, and pantoprazole which more promptly inhibit acid secretion and are more potent with longer duration. Rabeprazole and esomeprazole are categorized as second generation PPIs.